Stay updated on Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial page.

Latest updates to the Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page revision label changed from Revision: v3.5.3 to Revision: v3.5.4, signaling a small editorial or formatting update to the Study Details page. This does not alter substantive study information or results.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedThe page’s footer software version was updated from “Revision: v3.5.0” to “Revision: v3.5.3.”SummaryDifference0.0%

- Check77 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0. The change appears to be a system version update without modifications to study data or page content.SummaryDifference0.0%

- Check91 days agoChange DetectedThe site revision was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check112 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2 with no visible changes to study details or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check119 days agoChange DetectedThe update shows a revision from v3.4.0 to v3.4.1, with no changes to the study details or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial page.